Lifecore Biomedical
LFCR
LFCR
100 hedge funds and large institutions have $199M invested in Lifecore Biomedical in 2025 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 27 increasing their positions, 30 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
10% less repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 30
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
98% less call options, than puts
Call options by funds: $5K | Put options by funds: $261K
Holders
100
Holding in Top 10
5
Calls
$5K
Puts
$261K
Top Buyers
| 1 | +$907K | |
| 2 | +$596K | |
| 3 | +$510K | |
| 4 |
Jane Street
New York
|
+$501K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$283K |
Top Sellers
| 1 | -$2.77M | |
| 2 | -$1.99M | |
| 3 | -$746K | |
| 4 |
BlackRock
New York
|
-$259K |
| 5 |
Morgan Stanley
New York
|
-$228K |
